NR3C2 and heart failure: For the heart failure management in older patients includes guideline‐directed medical therapy (GDMT) with beta‐blockers (carvedilol, 6.5 mg), ACE inhibitors (Lisinopril, 20 mg) and mineralocorticoid receptor antagonists (MRAs) (Eplerenone, 50 mg) that were initiated to improve survival and reduce hospitalizations.